Latest Corporate News

馃搮January 19, 2026 at 1:00 PM
Major corporate mergers dominate headlines including Boston Scientific's $14.5B Penumbra acquisition and Worthington Steel's Kloeckner takeover, amid strong bank earnings, AI-driven tech gains, and tariff threats impacting markets.
1

Boston Scientific Acquires Penumbra for $14.5 Billion

Boston Scientific entered a merger agreement on January 15, 2026, to acquire medtech firm Penumbra in a $14.5 billion deal, expanding its neurovascular portfolio.Source 2 This acquisition aims to strengthen Boston Scientific's position in the medical technology sector.Source 2 The deal highlights ongoing consolidation in healthcare medtech.Source 2

2

Worthington Steel Completes Kloeckner Takeover

Worthington Steel successfully entered a business combination agreement with Kloeckner & Co on January 15, creating a $9.5 billion revenue North American steel service center giant.Source 4 The merger promises $150 million in annual synergies, tripling Worthington's scale while maintaining strong margins.Source 4 It follows intense M&A activity in the steel industry.Source 4

3

Repare Therapeutics Shareholders Approve XenoTherapeutics Acquisition

Repare shareholders approved the acquisition by XenoTherapeutics with 99.76% support at a special meeting on January 19, 2026.Source 10 The deal awaits court approval on January 23, with closing expected by January 28.Source 10 This bolsters precision oncology capabilities for the acquirer.Source 10

4

Goldman Sachs Shares Surge on Record Equity Trading Revenue

Goldman Sachs shares rose 4.6% after reporting the highest equity trading revenue among Wall Street banks, driving strong banking sector results.Source 1 Major banks showed robust performance buoyed by trading revenues despite some divergences.Source 1 Investor focus remains on individual bank report cards.Source 1

5

TSMC Reports 25.5% YoY Revenue Growth, Raises AI Margin Guidance

Taiwan Semiconductor Manufacturing Company delivered 25.5% year-on-year Q4 revenue growth and raised long-term gross margin guidance above 56%.Source 1 Results alleviate concerns over AI demand sustainability in tech sector.Source 1 TSMC's performance supported broader technology gains.Source 1

6

Alibaba Health Surges 17.9% on AI Health Assistant Success

Alibaba Health jumped 17.9% amid optimism for AI in healthcare, with 'Ant Afu' exceeding 30 million monthly users post-launch.Source 1 Parent Alibaba gained 13.5% after Qwen AI upgrades.Source 1 Validates strong market demand for AI-powered health services.Source 1

7

Japan Steel Works Resolves Subsidiary Absorption-Type Merger

Japan Steel Works approved an absorption-type merger of wholly-owned subsidiary M&E on January 19, 2026, effective April 1.Source 8 Aims to integrate functions amid challenging business environment post-2020 reorganization.Source 8 Follows policy decision from April 2025.Source 8

8

Cosegic Acquires Compliance Consultancy Fintrail

UK firm Cosegic acquired Fintrail to enhance financial crime and regulatory risk expertise on January 19, 2026.Source 6 Entire Fintrail team joins to strengthen client culture and resilience.Source 6 Follows recent Waystone UK compliance business transfer.Source 6

9

Netflix to Acquire Warner Bros Studio Operations

Investors watch Netflix's capital allocation after announcing acquisition of Warner Bros' studio operations.Source 1 Comes amid focus on key corporate earnings influencing sector sentiment.Source 1 Highlights streaming and content consolidation trends.Source 1

10

Intel's Foundry Expansion Draws Attention Amid Earnings

Intel's turnaround narrative under spotlight as it seeks foundry market share growth with new products.Source 1 Scheduled for quarterly earnings release this week alongside United Airlines and 3M.Source 3 Critical for semiconductor sector outlook.Source 1Source 3

11

Trip.com Plummets 21.8% on Antitrust Probe

Trip.com shares dropped amid Chinese antitrust investigation for market dominance abuse.Source 1 Regulatory intervention tempered market sentiment mid-week.Source 1 Part of broader China regulatory actions including margin financing curbs.Source 1